Special Session

Gordon B. Mills, M.D., Ph.D.

Gordon B. Mills, MD, PhD, Director of Precision Oncology, Director of SMMART trials, and holds the Wayne and Julie Drinkward Endowed Chair in Precision Oncology in the Knight Cancer Institute. Responsible for the implementation of an integrated program of tumor analysis, decision-making and implementation of novel precision oncology trials. His studies have identified multiple novel drug combinations and has translated these to the clinic. Dr. Mills has published more than 1000 papers and holds more than 20 patents, and served as principal investigator or project investigator on national peer-reviewed grants including NIH/NCI SPOREs and team grants (U01, U2C and U54), Stand Up To Cancer, Breast Cancer Research Foundation, Ovarian Cancer Research Foundation, and Komen Foundation. His efforts have been recognized in the Komen Foundation’s Brinker Award for Scientific Excellence, the Finneran Family Prize for Translational Research, the AACR Team Science Award, the Society of Gynecologic Oncology Career Award for Innovative Research and been elected to the AACR Academy. Nominated for and awarded multiple mentoring awards: Stand Up 2 Cancer Laura Ziskin Prize for Mentoring and the inaugural Waun Ki Hong award for mentorship. At the Knight, he plays a major role in the mentoring, and career develop for young scientists and physician scientists.